Use of the Optum Labs data warehouse to assess test ordering patterns for diagnosis of Helicobacter pylori infection in the united states

Journal of Clinical Microbiology

Volumn 53, Issue 4, 2015, Pages 1358-1360

  Theel, Elitza S ^a   Johnson, Ryan D ^a,b   Plumhoff, Elizabeth ^a   Hanson, Curtis A ^a  

^a MAYO CLINIC   (United States)

^b OPTUM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTON PUMP INHIBITOR;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEROLOGY; STOOL ANTIGEN TEST; UNITED STATES; UREA BREATH TEST; BLOOD; FACTUAL DATABASE; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

HELICOBACTER PYLORI;

ANTIBODIES, BACTERIAL; DATABASES, FACTUAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; SEROLOGIC TESTS; UNITED STATES;

EID: 84925235477     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03464-14     Document Type: Article

References (13)

1. Go MF. 2002. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 16(Suppl 1):S3-S15.
2. Brown LM. 2000. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283-297. http://dx.doi.org/10.1093/oxfordjournals.epirev.a018040.
3. Testerman TL, Morris J. 2014. Beyond the stomach: an updated view of pathogenesis, diagnosis, and treatment. World J Gastroenterol 20:12781-12808. http://dx.doi.org/10.3748/wjg.v20.i36.12781.
4. Crew KD, Neugut AI. 2006. Epidemiology of gastric cancer. World J Gastroenterol 12:354-362.
5. Cosme A, Montes M, Martos M, Gil I, Mendarte U, Salicio Y, Pineiro L, Recasens MT, Ibarra B, Sarasqueta C, Bujanda L. 2013. Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori. Clin Microbiol Infect 19:379-383. http://dx.doi.org/10.1111/j.1469-0691.2012.03844.x.
6. Sonnenberg A, Olson CA, Zhang J. 1999. The effect of antibiotic therapy on bleeding from duodenal ulcer. Am J Gastroenterol 94:950-954. http://dx.doi.org/10.1111/j.1572-0241.1999.992-o.x.
7. Laine L, Hopkins RJ, Girardi LS. 1998. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol 93:1409-1415.
8. Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, Tari A, Kitadai Y, Matsumoto H, Nagaya T, Kamoshida T, Watanabe N, Chiba T, Origasa H, Asaka M. 2012. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61:507-513. http://dx.doi.org/10.1136/gutjnl-2011-300495.
9. Patel SK, Pratap CB, Jain AK, Gulati AK, Nath G. 2014. Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol 20:12847-12859. http://dx.doi.org/10.3748/wjg.v20.i36.12847.
10. Chey WD, Wong BC. 2007. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102:1808-1825. http://dx.doi.org/10.1111/j.1572-0241.2007.01393.x.
11. Talley NJ, Vakil NB, Moayyedi P. 2005. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 129:1756-1780. http://dx.doi.org/10.1053/j.gastro.2005.09.020.
12. Centers for Medicare and Medicaid. 2014. Physician fee schedule. https://www.cms.gov/apps/physician-fee-schedule/overview.aspx.
13. Wallace PJ, Shah ND, Dennen T, Bleicher PA, Crown WH. 2014. Optum Labs: building a novel node in the learning health care system. Health Aff (Millwood) 33:1187-1194. http://dx.doi.org/10.1377/hlthaff.2014.0038.